medtronic inc the food and drug administration completed an investigation of safety issues raised by a former medtronic inc employee about a wireless device used to treat heart failure the agency said nothing was found that would have influenced its decision to approve the device called concerto which was approved by the fda in may medtronic spokesman rob clark said the company also thoroughly investigated the concerns and either addressed them or found them without merit 
